An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer

Published:2011-09 Issue:3 Volume:10 Page:171-177
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Cohn Allen L.,Shumaker Grace C.,Khandelwal Pankaj,Smith David A.,Neubauer Marcus A.,Mehta Nilesh,Richards Donald,Watkins David L.,Zhang Kathy,Yassine Mohamed R.

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference14 articles.

1. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer;Van Cutsem;J Clin Oncol,2007

2. Vectibix® (panitumumab) prescribing information,2010

3. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;Amado;J Clin Oncol,2008

4. Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab alone;Freeman;Clin Colorectal Cancer,2008

5. Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies;Benvenuti;Cancer Res,2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and characterization of anti-G12V mutated K-Ras monoclonal antibodies using hybridoma technology;Asia Pacific Journal of Molecular Biology and Biotechnology;2023-12-02

2. A review of targeted therapy and immune checkpoint inhibitors for metastatic colorectal cancer;Surgical Oncology;2023-12

3. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review;World Journal of Gastrointestinal Surgery;2023-04-27

4. Comprehensive review of targeted therapy for colorectal cancer;Signal Transduction and Targeted Therapy;2020-03-20

5. Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer;Cancer;2019-08-21